DealBook: Amgen Said to Be Near Deal to Buy Onyx for $10.5 Billion

The biotech giant Amgen near a deal to buy Onyx Pharmaceuticals, a maker of cancer-fighting drugs, for about $125 a share, people briefed on the matter said on Saturday.


Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.